a double-blind cross-over study was performed to compare the efficacy in maturity-onset ( type 2 ) diabetes of two glibenclamide preparations , hb 419 , currently in general use , and hb 420 , a new product with more complete absorption .
C0011860
type 2
C0017628
glibenclamide